belumosudil mesylate
Marketedupdated 2mo agoby Kadmon Pharmaceuticals LLC
Approvedcommunity read0 votes
all catalysts(5)
approval · 5
Jul 16, 2021
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
Nov 9, 2023
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
Apr 10, 2024
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
Dec 30, 2024
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
Jan 15, 2026
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that